Financhill
Back

Travere Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

Travere Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 35.35 Sell
20-day SMA: 35 Buy
50-day SMA: 30.62 Buy
200-day SMA: 21.14 Buy
8-day EMA: 35.11 Buy
20-day EMA: 34.41 Buy
50-day EMA: 31.04 Buy
200-day EMA: 22.96 Buy

Travere Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.24 Buy
Relative Strength Index (14 RSI): 58.4 Buy
Chaikin Money Flow: 686856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.2722 - 36.1122) Buy
Bollinger Bands (100): (17.7907 - 31.7907) Buy

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Travere Therapeutics, Inc. Stock

Is Travere Therapeutics, Inc. Stock a Buy?

TVTX Technical Analysis vs Fundamental Analysis

Buy
60
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy or a Sell?

Travere Therapeutics, Inc. Stock Info

Market Cap:
3.2B
Price in USD:
35.3300
Share Volume:
1.4M

Travere Therapeutics, Inc. 52-Week Range

52-Week High:
37.5000
52-Week Low:
12.9100
Buy
60
Travere Therapeutics, Inc. (TVTX) is a Buy

Travere Therapeutics, Inc. Share Price Forecast

Is Travere Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Travere Therapeutics, Inc.

Is Travere Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Technical Analysis of Travere Therapeutics, Inc.

Should I short Travere Therapeutics, Inc. stock?

* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.